IXICO (LSE:IXI) Institutional Ownership: 30.57% (As of Jul. 11, 2026)


What is IXICO Institutional Ownership?

IXICO LSE:IXI +1.65% Institutional Ownership is 30.57% as of Jul. 11, 2026. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IXICO's institutional ownership is 30.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IXICO's Insider Ownership is 3.05%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IXICO's Float Percentage Of Total Shares Outstanding is 0.00%.

IXICO Institutional Ownership Historical Data

* Premium members only.

The historical data trend for IXICO's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO Institutional Ownership Chart

IXICO Historical Data

The historical data trend for IXICO can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 14.78 14.78 14.78 11.09 11.09 11.09 10.98 12.99 30.57 30.57

IXICO Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 30.57% mean?
IXICO (LSE:IXI) has a Institutional Ownership of 30.57% as of Jul. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on IXICO and its competitors.
Is IXICO's Institutional Ownership too high?
IXICO's current Institutional Ownership is 30.57%.
How does IXICO's Institutional Ownership compare to VRTX and REGN?
IXICO's Institutional Ownership of 30.57% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on IXICO and its competitors. IXICO's current Institutional Ownership is 30.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
Based on GuruFocus' analysis, IXICO (LSE:IXI) is currently considered Modestly Overvalued. The stock's GF Value™ is £0.08, compared to a current price of £0.09 — trading 15.6% above its estimated fair value. The current Institutional Ownership is 30.57%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For IXICO (LSE:IXI), the current Institutional Ownership is 30.57% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IXICO Business Description

Address 15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.